CD45-deficient mice accumulate pro-B cells both in vivo and in vitro

Journal of Immunology

Volumn 173, Issue 4, 2004, Pages 2542-2551

  Fleming, Heather E ^b   Milne, Craig D ^a   Paige, Christopher J ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE DIFFERENTIATION FACTOR; B LYMPHOCYTE GROWTH FACTOR; B LYMPHOCYTE RECEPTOR; CD45 ANTIGEN; GROWTH FACTOR RECEPTOR; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR; INTERLEUKIN 7 RECEPTOR ALPHA; JANUS KINASE; PRE B LYMPHOCYTE RECEPTOR; PROTEIN; PROTEIN SERINE KINASE; PROTEIN TYROSINE PHOSPHATASE; STAT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; BONE MARROW CELL; CELL LINEAGE; CELL SURVIVAL; CONTROLLED STUDY; HEMATOPOIETIC CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

EID: 4043114170     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.173.4.2542     Document Type: Article

References (43)

1. Meffre, E., R. Casellas, and M. C. Nussenzweig. 2000. Antibody regulation of B cell development. Nat. Immunol. 1:379.
2. Stoddart, A., H. E. Fleming, and C. J. Paige. 2000. The role of the preBCR, the interleukin-7 receptor, and homotypic interactions during B-cell development. Immunol. Rev. 175:47.
3. Fleming, H. E., and C. J. Paige. 2001. Pre-B cell receptor signaling mediates selective response to IL-7 at the pro-B to pre-B cell transition via an ERK/MAP kinase-dependent pathway. Immunity 15:521.
4. Kurosaki, T. 1998. Molecular dissection of B cell antigen receptor signaling. Int. J. Mol. Med. 1:515.
5. fyn through a segment of its cytoplasmic tail. Proc. Natl. Acad. Sci. USA 89:12083.
6. Zeng, Y. X., H. Takahashi, M. Shibata, and K. Hirokawa. 1994. JAK3 Janus kinase is involved in interleukin 7 signal pathway. FEBS Lett. 353:289.
7. Venkitaraman, A. R., and R. J. Cowling. 1994. Interleukin-7 induces the association of phosphatidylinositol 3-kinase with the a chain of the interleukin-7 receptor. Eur. J. Immunol. 24:2168.
8. Corcoran, A. E., F. M. Smart, R. J. Cowling, T. Crompton, M. J. Owen, and A. R. Venkitaraman. 1996. The interleukin-7 receptor a chain transmits distinct signals for proliferation and differentiation during B lymphopoiesis. EMBO J. 15:1924.
9. Hofmeister, R., A. R. Khaled, N. Benbemou, E. Rajnavolgyi, K. Muegge, and S. K. Durum. 1999. Interleukin-7: physiological roles and mechanisms of action. Cytokine Growth Factor Rev. 10:41.
10. Thomas, M. L. 1989. The leukocyte common antigen family. Annu. Rev. Immunol. 7:339.
11. Deans, J. P., A. W. Boyd, and L. M. Pilarski. 1989. Transitions from high to low molecular weight isoforms of CD45 (T200) involve rapid activation of alternate mRNA splicing and slow turnover of surface CD45R. J. Immunol. 143:1233.
12. Hathcock, K. S., H. Hirano, and R. J. Hodes. 1993. CD45 expression by murine B cells and T cells: alteration of CD45 isoforms in subpopulations of activated B cells. Immunol. Res. 12:21.
13. Payne, K. J., K. L. Medina, and P. W. Kincade. 1999. Loss of c-kit accompanies B-lineage commitment and acquisition of CD45R by most murine B-lymphocyte precursors. Blood 94:713.
14. + cells in murine bone marrow does not express CD19 and contains natural killer cell progenitors. J. Exp. Med. 183:187.
15. Justement, L. B. 1997. The role of CD45 in signal transduction. Adv. Immunol. 66:1.
16. Pao, L. I., W. D. Bedzyk, C. Persin, and J. C. Cambier. 1997. Molecular targets of CD45 in B cell antigen receptor signal transduction. J. Immunol. 158:1116.
17. - B cells. J. Immunol. 158:2663.
18. D'Oro, U., and J. D. Ashwell. 1999. Cutting edge: the CD45 tyrosine phosphatase is an inhibitor of Lck activity in thymocytes. J. Immunol. 162:1879.
19. Katagiri, T., M. Ogimoto, K. Hasegawa, Y. Arimura, K. Mitomo, M. Okada, M. R. Clark, K. Mizuno, and H. Yakura. 1999. CD45 negatively regulates lyn activity by dephosphorylating both positive and negative regulatory tyrosine residues in immature B cells. J. Immunol. 163:1321.
20. Irie-Sasaki, J., T. Sasaki, W. Matsumoto, A. Opavsky, M. Cheng, G. Welstead, E. Griffiths, C. Krawczyk, C. D. Richardson, K. Aitken, et al. 2001. CD45 is a JAK phosphatase and negatively regulates cytokine receptor signalling. Nature 409:349.
21. Yamada, T., D. Zhu, A. Saxon, and K. Zhang. 2002. CD45 controls interleukin-4-mediated IgE class switch recombination in human B cells through its function as a Janus kinase phosphatase. J. Biol. Chem. 277:28830.
22. Kishihara, K., J. Penninger, V. A. Wallace, T. M. Kundig, K. Kawai, A. Wakeham, E. Timms, K. Pfeffer, P. S. Ohashi. M. L. Thomas, et al. 1993. Normal B lymphocyte development but impaired T cell maturation in CD45-exon6 protein tyrosine phophatase-deficient mice. Cell 74:143.
23. + thymocytes, and B cell maturation. J. Exp. Med. 183:1707.
24. Marshall, A. J., H. E. Fleming, G. E. Wu, and C. J. Paige. 1998. Modulation of the IL-7 dose-response threshold during pro-B cell differentiation is dependent on pre-B cell receptor expression. J. Immunol. 161:6038.
25. Stoddart, A., H. E. Fleming, and C. J. Paige. 2001. The role of homotypic interactions in the differentiation of B cell precursors. Eur. J. Immunol. 31:1160.
26. Ray, R. J., A. Stoddart, J. L. Pennycook, H. O. Huner, C. Furlonger, G. E. Wu, and C. J. Paige. 1998. Stromal cell-independent maturation of IL-7-responsive pro-B cells. J. Immunol. 160:5886.
27. Lyons, A. B. 2000. Analyzing cell division in vivo and in vitro using flow cytometric measurement of CFSE dye dilution. J. Immunol. Methods 243:147.
28. Hardy, R., C. Carmack, S. Shinton, J. Kemp, and K. Hayakawa. 1991. Resolution and characterization of pro-B and pre-pro-B cell stages in normal mouse bone marrow. J. Exp. Med. 173:1213.
29. Benatar, T., R. Carsetti, C. Furlonger, N. Kamalia, T. Mak, and C. J. Paige. 1996. Immunoglobulin-mediated signal transduction in B cells from CD45-deficient mice. J. Exp. Med. 183:329.
30. Fleming, H. E., and C. J. Paige. 2002. Cooperation between IL-7 and the pre-B cell receptor: a key to B cell selection. Semin. Immunol. 14:423.
31. Fernandis, A. Z., R. P. Cherla, and R. K. Ganju. 2003. Differential regulation of CXCR4-mediated T-cell chemotaxis and mitogen-activated protein kinase activation by the membrane tyrosine phosphatase, CD45. J. Biol. Chem. 278:9536.
32. Ma, Q., D. Jones, P. R. Borghesani, R. A. Segal, T. Nagasawa, T. Kishimoto, R. T. Bronson, and T. A. Springer. 1998. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc. Natl. Acad. Sci. USA 95:9448.
33. Sudo, T., S. Nishikawa, N. Ohno, N. Akiyama, M. Tamakoshi, and H. Yoshida. 1993. Expression and function of the interieukin 7 receptor in murine lymphocytes. Proc. Natl. Acad. Sci. USA 90:9125.
34. Smart, F. M., and A. R. Venkitaraman. 2000. Inhibition of interleukin 7 receptor signaling by antigen receptor assembly. J. Exp. Med. 191:737.
35. Symons, A., D. N. Cooper, and A. N. Barclay. 2000. Characterization of the interaction between galectin-1 and lymphocyte glycoproteins CD45 and Thy-1. Glycobiology 10:559.
36. Bakker, T. R., C. Piperi, E. A. Davies, and P. A. Merwe. 2002. Comparison of CD22 binding to native CD45 and synthetic oligosaccharide. Eur. J. Immunol. 32:1924.
37. Stoddart, A., R. J. Ray, and C. J. Paige. 1997. Analysis of murine CD22 during B cell development: CD22 is expressed on B cell progenitors prior to IgM. Int. Immunol. 9:1571.
38. Gauthier, L., B. Rossi, F. Roux, E. Termine, and C. Schiff. 2002. Galectin-1 is a stromal cell ligand of the pre-B cell receptor (BCR) implicated in synapse formation between pre-B and stromal cells and in pre-BCR triggering. Proc. Natl. Acad. Sci. USA 99:13014.
39. Majeti, R., Z. Xu, T. G. Parslow, J. L. Olson, D. I. Daikh, N. Killeen, and A. Weiss. 2000. An inactivating point mutation in the inhibitory wedge of CD45 causes lymphoproliferation and autoimmunity. Cell 103:1059.
40. Xu, Z., and A. Weiss. 2002. Negative regulation of CD45 by differential homodimerization of the alternatively spliced isoforms. Nat. Immunol. 3:764.
41. Ledbetter, J. A., G. L. Schieven, F. M. Uckun, and J. B. Imboden. 1991. CD45 cross-linking regulates phospholipase C activation and tyrosine phosphorylation of specific substrates in CD3/Ti-stimulated T cells. J. Immunol. 146:1577.
42. Amano, M., M. Galvan, J. He, and L. G. Baum. 2003. The ST6Gal I sialyltransferase selectively modifies N-glycans on CD45 to negatively regulate galectin-1-induced CD45 clustering, phosphatase modulation, and T cell death. J. Biol. Chem. 278:7469.
43. Ogilvy, S., C. Louis-Dit-Sully, J. Cooper, R. L. Cassady, D. R. Alexander, and N. Holmes. 2003. Either of the CD45RB and CD45RO isoforms are effective in restoring T cell, but not B cell, development and function in CD45-null mice. J. Immunol. 171:1792.